Recently, Xi'an DELI Biochemical announced new progress in the application of Betadex Sulfobutyl Ether Sodium (SBECD) at its research facility in Xi'an, China. Driven by the growing demand for effective formulation solutions for poorly soluble drugs, the company's scientists optimized inclusion complex technology to enhance drug solubility and stability. The achievement highlights the important role of SBECD in modern drug delivery systems and supports the development of high-quality pharmaceutical products worldwide.
Xi’an DELI Biochemical Industry Co., Ltd., a professional manufacturer of cyclodextrin derivatives and pharmaceutical excipients, is pleased to announce its participation in two major international pharmaceutical exhibitions in Shanghai: API China 2026 and CPHI China 2026.
Cyclodextrin vs Hydroxypropyl Betadex: compare cost, solubility performance, safety, regulatory status and development timeline to choose the best excipient for pharmaceutical formulation optimization and drug delivery systems.
Vonoprazan Fumarate has emerged as a next-generation solution for managing acid-related gastrointestinal disorders. Unlike conventional therapies, it delivers rapid, consistent, and long-lasting acid suppression, addressing common patient concerns such as delayed symptom relief, incomplete healing, and nighttime acid breakthrough. This article provides a comprehensive exploration of its mechanism, benefits, applications, and practical considerations for buyers and healthcare stakeholders.
Hydroxypropyl Betadex (HPBCD) is a widely used pharmaceutical excipient known for improving the solubility, stability, and bioavailability of poorly water-soluble drugs. By forming inclusion complexes, it enhances drug performance across oral, injectable, and ophthalmic formulations. Its excellent compatibility and safety profile make it a key material in modern drug development. With reliable quality and stable supply, HPBCD supports pharmaceutical companies in optimizing formulations and accelerating product development for global markets.
